{
  "study_metadata": {
    "study_id": null,
    "design": "RCT"
  },
  "exposure": {
    "label": "oral resveratrol",
    "comparator": "placebo"
  },
  "outcomes": [
    {
      "name": "HOMA_IR",
      "timepoint_weeks": 4,
      "arm_name": "intervention",
      "n": 10,
      "baseline_mean": null,
      "baseline_sd": null,
      "followup_mean": null,
      "followup_sd": null,
      "units": "unitless"
    }
  ],
  "comment_detailed": "The study reports a 4‑week double‑blind RCT with 10 resveratrol and 9 placebo patients. Only the change in HOMA‑IR is provided (21.52 ± 1.18 vs 0.04 ± 1.4). Absolute baseline and follow‑up means are not given, so they are set to null. No HbA1c change data are available. The evidence is limited to the reported mean changes and sample sizes.",
  "missing_fields": [
    "study_metadata.study_id",
    "outcomes[0].baseline_mean",
    "outcomes[0].baseline_sd",
    "outcomes[0].followup_mean",
    "outcomes[0].followup_sd"
  ],
  "evidence": [
    "\"resveratrol group: 21.52 (SD 1.18) vs placebo 0.04 (SD 1.4)\"",
    "\"19 patients, 10 resveratrol, 9 placebo\""
  ],
  "comment": "Only change data available",
  "confidence": 0.7
}